echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > How to "learn from yew" to synthesize anti-cancer star drugs efficiently

    How to "learn from yew" to synthesize anti-cancer star drugs efficiently

    • Last Update: 2021-08-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Yew fruit Photo courtesy of Zhang Xiao, Tsinghua University

    Yew fruit Photo courtesy of Zhang Xiao, Tsinghua University

    To efficiently synthesize paclitaxel, the star anti-cancer drug with complex molecular structure, humans have to "learn from" the cherished endangered plant yew


    On July 15, the Institute of Genomics of the Chinese Academy of Agricultural Sciences (Shenzhen) (hereinafter referred to as the Institute of Genomics) and Hunan Agricultural University jointly published a high-quality reference genome at the chromosome level of Taxus chinensis in Nature-Plants and comprehensively analyzed it.


    Unsustainable: Star anti-cancer drugs rely heavily on rare and endangered plants

    Unsustainable: Star anti-cancer drugs rely heavily on rare and endangered plants

    "Plant giant panda" yew is a rare and endangered plant in China, and it is also called "national treasure" by 42 countries around the world


    Taxol, a unique diterpene compound produced by yew, was first isolated and identified from the bark of yew in the 1960s


    At present, as a star antitumor drug of plant origin with the best known curative effect, paclitaxel can specifically regulate tubulin to inhibit the abnormal division and proliferation of tumor cells.


    It is reported that the chemical structure of paclitaxel is extremely complex, containing 47 carbon atoms, 11 stereo centers, multiple chiral centers and functional groups.


    "However, the content of paclitaxel in yew is very low, and the growth of yew is very slow, causing the current contradiction between the supply and demand of paclitaxel


    "However, there is a lack of guidance from the yew genome data and the taxol biosynthesis pathway has not been fully resolved.


    Successfully assembled the chromosome-level genome of Taxus chinensis

    Successfully assembled the chromosome-level genome of Taxus chinensis

    There are 11 species of yew in the world.


    According to Xiong Xingyao, a researcher at the Institute of Genomics, Taxus chinensis is mainly distributed in provinces south of the Yangtze River basin, and is mostly distributed in southern provinces of China, including Henan and Shaanxi


    The team selected haplotype endosperm materials of Taxus chinensis for whole genome sequencing, and successfully assembled a high-quality reference genome at the chromosome level


    Genomic characteristics of Taxus chinensis var.


    Genomic characteristics of Taxus chinensis var.


    At the same time, "the team's multi-omics research system on tomatoes and cucumbers provides a powerful tool for the analysis of paclitaxel metabolic pathways


    The study found that the genome of Taxus chinensis has undergone an ancient whole-genome replication event, and the repetitive sequences in its genome have undergone a long-term and continuous insertion process


    Yan Jianbin explained, “The discovery of genome-wide duplication and continuous insertion of repeated sequences explains to a certain extent the reason why the genome of Taxus chinensis has become larger
    in the course of evolution.
    At the same time, compared with other gymnosperms during the long evolutionary process, Taxus chinensis has evolved to form a unique family of Gypsy and Copia transposons, which reflects the genetic uniqueness of yew as a'plant giant panda' from a genomic perspective
    .
    "

    Revealing the genetic basis of paclitaxel biosynthesis

    Revealing the genetic basis of paclitaxel biosynthesis

    Not only that, yew has also evolved a unique family of genes related to taxol biosynthesis
    .

    "Taxol can only be synthesized in Taxus chinensis, which is closely related to its unique gene family
    .
    " Yan Jianbin said that the research system analyzed the location and coordinated expression regulation of genes related to paclitaxel synthesis, and mapped the location of multiple related gene families.
    In particular, it revealed the genomic distribution and regulation of the cytochrome P450 family, especially the taxol synthesis-related P450 subfamily (CYP725A)
    .

    "Whether the taxol synthase gene has a coordinated distribution and regulation on the genome has been unknown before
    .
    " Yan Jianbin said that their research further found that the taxol synthesis-related gene has an aggregated distribution on the chromosome of Taxus chinensis and is coordinated by the plant hormone jasmin.
    Trends, identified the taxus-specific CYP725A family and the first taxol biosynthesis gene cluster consisting of six genes in tandem, and is mainly responsible for catalyzing the first two steps of taxol biosynthesis
    .

    Professor Deng Zixin, an academician of the Chinese Academy of Sciences, spoke highly of the research progress.
    Since the discovery of paclitaxel, scientists have completed more than half a century of research on its structure-activity relationship, drug formulation, drug source, clinical application, and mechanism of action.
    Research work
    .
    Today, Chinese scientists have completed the sequencing and assembly of the Taxus chinensis genome, which provides an important cornerstone for solving the key scientific problem of "How does the yew synthesize taxol"
    .

    "The distribution and regulation of taxol biosynthesis genes discovered in this research, based on the candidate genes obtained from multi-omics analysis, are of great significance for guiding taxus genetics and breeding and the efficient use of germplasm resources; Paclitaxel synthetic biology biomanufacturing provides biological data assurance, speeds up the design and development of paclitaxel heterogeneous synthesis chassis, and provides a key foundation for the next step in the development of a green, environmentally friendly and sustainable production strategy for paclitaxel biosynthesis
    .
    " said Deng Zixin
    .

    The co-first authors of the paper are researcher Xiong Xingyao of the Institute of Genomics, postdoctoral fellow Gou Junbo, research assistant Liao Qinggang, and associate professor Li Yanlin of Hunan Agricultural University
    .
    Researchers of the Institute of Genomics Yan Jianbin and Huang Sanwen are the co-corresponding authors of the paper
    .
    The first item funded by the project is marked as the National Key Research and Development Program of Synthetic Biology
    .
    (Source: China Science News Li Chen)

    Related paper information: https://doi.
    org/10.
    1038/s41477-021-00963-5

    https://doi.
    org/10.
    1038/s41477-021-00963-5
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.